Molecular Therapy - Nucleic Acids

Slides:



Advertisements
Similar presentations
Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial Cells  Kai Fang, Aristea.
Advertisements

Molecular Therapy - Nucleic Acids
AntimiR-30b Inhibits TNF-α Mediated Apoptosis and Attenuated Cartilage Degradation through Enhancing Autophagy Cell Physiol Biochem 2016;40:
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Molecular Therapy - Nucleic Acids
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small.
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition  L. Enochson, J. Stenberg, M. Brittberg, A. Lindahl 
Regulation of mesenchymal stem cell chondrogenesis by glucose through protein kinase C/transforming growth factor signaling  T.-L. Tsai, P.A. Manner,
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Requirement of the NF-κB pathway for induction of Wnt-5A by interleukin-1β in condylar chondrocytes of the temporomandibular joint: functional crosstalk.
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 through the inhibition of the MAPK signaling pathway.
Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease  Sandhya S. Thomas, Yanjun Dong,
MiR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa  Michael Vanden Oever, Daniel Muldoon, Wendy Mathews, Ron McElmurry, Jakub.
N. Zhong, J. Sun, Z. Min, W. Zhao, R. Zhang, W. Wang, J. Tian, L
MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
How MicroRNAs Modify Protein Production
NF-κBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes  Dr C. Lianxu, Ph.D.,
Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like.
Human renal epithelial cells produce the long pentraxin PTX3
L. Raymond, S. Eck, E. Hays, I. Tomek, M. D. , S. Kantor, M. D. , M
Molecular Therapy - Nucleic Acids
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Bone morphogenetic protein 2/SMAD signalling in human ligamentocytes of degenerated and aged anterior cruciate ligaments  K. Ruschke, C. Meier, M. Ullah,
Molecular Therapy - Nucleic Acids
MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1β-induced chondrocyte responses  F. Meng, Z. Zhang, W.
CaMKII inhibition in human primary and pluripotent stem cell-derived chondrocytes modulates effects of TGFβ and BMP through SMAD signaling  B. Saitta,
Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene  H. Li, D.R. Haudenschild,
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Molecular Therapy - Nucleic Acids
Pseudomonas Aeruginosa- and IL-1β-Mediated Induction of Human β-Defensin-2 in Keratinocytes Is Controlled by NF-κB and AP-1  Kai Wehkamp, Lars Schwichtenberg,
Expression and regulation of Toll-like receptor 2 by IL-1β and fibronectin fragments in human articular chondrocytes  S.-L. Su, M.S., C.-D. Tsai, Ph.D.,
MiR-146a Negatively Regulates TLR2-Induced Inflammatory Responses in Keratinocytes  Florian Meisgen, Ning Xu Landén, Aoxue Wang, Bence Réthi, Charbel.
Molecular Therapy - Nucleic Acids
Isoliquiritigenin Inhibits IL-1β-Induced Production of Matrix Metalloproteinase in Articular Chondrocytes  Lei Zhang, Shiyun Ma, Hang Su, Jiaxiang Cheng 
Volume 23, Issue 10, Pages (October 2015)
Volume 23, Issue 8, Pages (August 2015)
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent
Identification and Functional Characterization of RSPO2 as a Susceptibility Gene for Ossification of the Posterior Longitudinal Ligament of the Spine 
Different responses of healthy, relative healthy and OA chondrocytes with IL1β treatment under hypoxia and normoxia  X. Huang, L. Zhong, J. Post, M. Karperien 
Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes  L.A. Vonk, A.H.M. Kragten,
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells  T. Tetsunaga,
Molecular Therapy - Nucleic Acids
Differential Gene Induction of Human β-Defensins (hBD-1, -2, -3, and -4) in Keratinocytes Is Inhibited by Retinoic Acid  Jürgen Harder, Ulf Meyer-Hoffert,
Molecular Therapy - Nucleic Acids
A peptide temporally enhanced chondrogenesis of mesenchymal stem cells
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 6, Issue 3, Pages (March 2016)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 24, Issue 10, Pages (October 2016)
Volume 22, Issue 10, Pages (October 2014)
Volume 22, Issue 6, Pages (June 2014)
Molecular Therapy - Nucleic Acids
Volume 22, Issue 9, Pages (September 2014)
Molecular Therapy - Nucleic Acids
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Volume 24, Issue 10, Pages (October 2016)
Figure 4. MicroRNA (miR)-195 and miR-497 directly targets CD274
Inhibition of miR-449a Promotes Cartilage Regeneration and Prevents Progression of Osteoarthritis in In Vivo Rat Models  Dawoon Baek, Kyoung-Mi Lee, Ki.
Volume 23, Issue 4, Pages (April 2015)
Presentation transcript:

Molecular Therapy - Nucleic Acids microRNA-140 Inhibits Inflammation and Stimulates Chondrogenesis in a Model of Interleukin 1β-induced Osteoarthritis  Tommy A Karlsen, Gustavo Antonio de Souza, Bjørn Ødegaard, Lars Engebretsen, Jan E Brinchmann  Molecular Therapy - Nucleic Acids  Volume 5, (January 2016) DOI: 10.1038/mtna.2016.64 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Upregulation of OA-associated genes in response to rhIL1B. (a) RT-qPCR analysis of IL1B, IL8, and MMP13 mRNA levels after stimulating ACs with increasing doses of rhIL1B. (b) RT-qPCR analysis of IL1B, IL8, and MMP13 mRNA levels after stimulating bone-marrow-derived mesenchymal stem cells (BM-MSCs) with increasing doses of rhIL1B. (c) Expression of IL1B, IL6, IL8, and MMP13 during 48 hours of stimulation with rhIL1B 0.1 ng/ml. (d) Expression of IL1B, IL6, IL8, and MMP13 during 7 days of stimulation with rhIL1B 0.1 ng/ml. Cells used in a, b, c, and d are from four different donors. Numbers in parentheses indicate relative fold change values relative to time zero or the first detectable value. N.D, not detected; OA, osteoarthritis; IL1B, interleukin 1β; RT-qPCR, real time-quantitative polymerase chain reaction; rhIL1B, recombinant human IL1B; MMP13, matrix metalloprotein 13. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.64) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Functional analysis of miR-140 2 days after electroporation. (a) RT-qPCR analysis of miR-140 levels in ACs electroporated with a negative control sequence (Control), miR-140 and in native articular cartilage. (b) Relative expression of RALA, BMP2, and ADAMTS5 in control cells and miR-140 electroporated cells. Cells from three donors were used in a and b. U6 and GAPDH were used as a reference genes in a and b, respectively. In a and b the cells were stimulated for 20 hours before analysis. In c the cells were stimulated for 0, 30 minutes, 1, 3, 5, 8, 20, and 48 hours. In d the cells were stimulated for 1, 2, 5, and 7 days. Min, minutes; h, hours. RT-qPCR, real time-quantitative polymerase chain reaction; ACs, articular chondrocytes. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.64) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Results of miR-140 overexpression in rhIL1B stimulated ACs. The cells were electroporated with a negative control sequence or miR-140. The following day the cells were stimulated with rhIL1B for 20 hours before analysis. RT-qPCR analysis of IL1B, IL6, IL8, CCL5, ADAMTS4, and MMP13 in ACs (a) and synovial fibroblasts (SFs) (b). Numbers in parentheses indicate fold change values relative to results for control transfection plus IL1B stimulation. Differentially shaded bars indicate the different genes. IL1B, interleukin 1β; RT-qPCR, real time-quantitative polymerase chain reaction; rhIL1B, recombinant human IL1B; MMP13, matrix metalloprotein 13; ACs, articular chondrocytes. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.64) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Impact of miR-140 overexpression on proteins involved in the NFKB signaling pathway. NFKB activators (upper right corner) and target genes (in the nucleus) of NFKB were downregulated by miR-140, while two inhibitors were upregulated (upper left corner). IL1B binds to IL1R1. This activates IRAK kinases and the IKK complex which phosphorylates the NFKB inhibitor IKB. Phosphorylated IKB is then ubiquitinated and degraded in the proteasome. This releases NFKB. NFKB1 or -2 heterodimerizes with REL, RELA or RELB, translocates into the nucleus and turns on transcription of NFKB target genes. IL1B, interleukin 1β. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.64) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Western blot analysis of inflammation and chondrogenesis proteins. (a) IKB protein levels were analyzed in unstimulated cells, after 30 minutes (min) and 20 hours (h) following rhIL1B stimulation. (b) IL1B, IL6, IL8, ACAN, SOX9, and CSGALNACT1 in cells electroporated with control or miR-140 for 1 day and subsequently stimulated with rhIL1B for 20 hours. ACTB was used as loading control in a and b. (c) RT-qPCR analysis of ACAN, SOX9, and CSGALNACT mRNA levels after electroporation with miR-140 and stimulation with rhIL1B. D1, Donor 1; D2, Donor 2; D3, Donor 3. IL1B, interleukin 1β; RT-qPCR, real time-quantitative polymerase chain reaction; rhIL1B, recombinant human IL1B. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.64) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 microRNA luciferase reporter assays. Luciferase reporter constructs containing the indicated 3′UTR and negative control miR (control) and miR-140 mimic were cotransfected into Lenti-X 293T cells. After 24 hours, the luciferase signal from the cells was detected by photon counting. Results were calculated from technical triplicates (n = 3) and shown as mean ± SD. 3′-UTR, 3′-untranslated region. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.64) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions